Flaharty Asset Management LLC Raises Holdings in UnitedHealth Group Incorporated $UNH

Flaharty Asset Management LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 111.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,358 shares of the healthcare conglomerate’s stock after buying an additional 715 shares during the quarter. Flaharty Asset Management LLC’s holdings in UnitedHealth Group were worth $424,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of UNH. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Markel Group Inc. lifted its position in UnitedHealth Group by 4.9% in the first quarter. Markel Group Inc. now owns 28,014 shares of the healthcare conglomerate’s stock worth $14,672,000 after buying an additional 1,300 shares during the last quarter. Independent Wealth Network Inc. increased its position in UnitedHealth Group by 8.4% during the first quarter. Independent Wealth Network Inc. now owns 503 shares of the healthcare conglomerate’s stock valued at $263,000 after acquiring an additional 39 shares during the last quarter. Finally, Jennison Associates LLC lifted its holdings in shares of UnitedHealth Group by 105.4% in the 1st quarter. Jennison Associates LLC now owns 502,076 shares of the healthcare conglomerate’s stock worth $262,962,000 after acquiring an additional 257,599 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on UNH shares. KeyCorp increased their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a report on Wednesday, October 29th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Down 3.3%

Shares of UnitedHealth Group stock opened at $321.44 on Friday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The stock has a market cap of $291.17 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 2.28 and a beta of 0.47. The firm’s 50-day moving average is $347.65 and its two-hundred day moving average is $320.06.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the firm earned $7.15 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.